Anna Mathew, MD, MPH

Assistant Professor, Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Phone: (516) 465-8202

About the Investigator

Dr. Anna Mathew joined Northwell Health in March 2013. Originally from Canada, she completed her clinical training at McGill University, the University of Toronto and Western University, attaining certification as a clinical nephrologist in 2010. In 2012, she attained a Master’s Degree in Public Health from Harvard University, focusing on Quantitative Methods. She has a keen interest in the patterns, causes and effects of kidney disease on the health of individuals and populations. She is also privileged to have an active clinical practice, seeing patients with kidney disease in hospital, and in the dialysis unit. Her clinical work fuels her to ask the important questions which need to be answered to improve outcomes for patients and health systems.

Research Focus
Dr. Mathew is a patient-oriented investigator. Her research interests lie in the clinical outcomes of patients with kidney disease and on dialysis. She uses several national databases to conduct epidemiologic studies on fracture rates in dialysis patients, mortality after kidney transplantation, and readmission to hospital in dialysis patients. Based on this data, she designs and tests evidence-based clinical interventions that can reduce the frequency of these costly and avoidable readmissions.


Harvard University
Degree: MPH

University of Toronto
Degree: MD

Honors and Awards

2016 NIH institute on Randomized Trials of Behavioral Interventions, Airlie, Virginia, Awarded through competitive application process
2016 EPIC Summer Program, Columbia University, Full scholarship for “Qualitative Analysis” course
2014 Spielman Award for Excellence in Research, North Shore-LIJ Health System
2009 International Nephrology Travel Fellowship, Canadian Society of Nephrology

  1. Mathew AT*, Obi Y*, Rhee CM, Chen JLT, Shah G, Lau W, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. “Treatment Frequency and Mortality Among Incident Hemodialysis Patients in the United States.” (in press: Kidney International)  *co-first authors
  2. Mathew AT, Obi Y, Fishbane S, Kalantar-Zadeh K. “Preservation of Residual Kidney Function in Hemodialysis Patients: Reviving an Old Concept for Contemporary Practice.” (in press: Kidney International)
  3. Obi Y, Rhee CM, Mathew AT, Shah G, Streja E, Brunelli SM, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. “Residual Kidney Function Decline and Mortality in Incident Hemodialysis Patients.” J Am Soc Neph. 2016 May (Epub ahead of print)
  4. Obi Y, Streja E, Rhee  CM, Ravel V, Amin AN, Cupisti A, Chen J, Mathew AT, Kovesdy CP, Mehrotra R, Kalantar-Zadeh K. “Incremental Hemodialysis, Residual Kidney Function, and Mortality Risk in Incident Dialysis Patients: A Cohort Study.” Am J Kid Dis. 2016 Feb (Epub ahead of print)
  5. Mathew AT, Strippoli G, Ruesposo M, Fishbane S. “Reducing Readmissions in Patients with End Stage Kidney Disease.”  Kidney Int. 2015; 88(6):1250-1260
  6. Mathew AT*, Kadiyala A*, Sachdeva M, Sison C, Shah H, Fishbane S, Jhaveri KD. “Outcomes of Renal Transplantation in Recipients with IgA Nephropathy: A UNOS/OPTN Analysis.”  2015; 29(10):911-9  *co-first authors
  7. Fishbane S, Hazzan AD, Halinski C, Mathew AT. “Challenges and opportunities in late-stage chronic kidney disease.” Clin Kidney J. 2015 Feb;8(1):54-60.
  8. Mathew AT, Hazzan A, Jhaveri KD, Block, GA, Chidella S, Rosen L, Wagner J, Fishbane S. “Increasing Hip Fracture in Patients Receiving Hemodialysis and Peritoneal Dialysis.” Am J Nephrol. 2014;40(5):451-457.
  9. Fishbane S, Mathew AT, Wanchoo R. “Intravenous Iron Exposure and Mortality in Patients on Hemodialysis.” (invited editorial) Clin J Am Soc Nephrol. 2014; 9(11):1837-9.
  10. Fishbane S, Mathew AT, Vaziri ND. “Iron toxicity: relevance for dialysis patients.” Nephrol Dial Transplant. 2014;29(2):255-9.

View more at PubMed